PRESS RELEASE published on 10/05/2023 at 13:00, 2 years 7 months ago Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE published on 09/29/2023 at 13:00, 2 years 7 months ago Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE published on 09/27/2023 at 13:00, 2 years 7 months ago Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE published on 09/21/2023 at 22:35, 2 years 7 months ago Theralase(R) Grants Stock Options
PRESS RELEASE published on 09/07/2023 at 10:30, 2 years 8 months ago Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE published on 08/29/2023 at 22:30, 2 years 8 months ago Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE published on 06/30/2023 at 22:35, 2 years 10 months ago Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE published on 06/06/2023 at 13:00, 2 years 11 months ago Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE published on 05/31/2023 at 03:30, 2 years 11 months ago Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE published on 05/31/2023 at 01:35, 2 years 11 months ago Theralase(R) Releases 1Q2023 Interim Financial Statements
Published on 05/16/2026 at 01:15, 16 hours 29 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 17 hours 44 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 18 hours 34 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 18 hours 44 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 1 hour 35 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 21 hours 34 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 23 hours 33 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 2 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 2 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 7 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 8 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 23 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES